Corpus Intelligence IC Memo — BAPTIST HEALTH REHABILITATION INSTIT 2026-04-26 05:31 UTC
IC Memo — BAPTIST HEALTH REHABILITATION INSTIT
Investment Committee Memorandum | AR | 120 beds | Grade C | EBITDA uplift $3.0M
🛡️ Public data only — no PHI permitted on this instance.
Investment Committee Memorandum

BAPTIST HEALTH REHABILITATION INSTIT

CCN 043026 | PULASKI, AR | 120 beds | April 26, 2026
EBITDA BridgeData Room
C
Investability

1. Target Overview & Investment Thesis

BAPTIST HEALTH REHABILITATION INSTIT is a 120-bed suburban community hospital in PULASKI, AR with $41.1M in net patient revenue and a 7.1% operating margin. The hospital serves a payer mix of 42.9% Medicare, 16.2% Medicaid, and 40.9% commercial.

Thesis: Turnaround. Our ML models identify $3.0M in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from 7.1% to 14.4% (+736bps).

Net Revenue HCRIS$41.1M
Current EBITDA COMPUTED$2.9M
Operating Margin COMPUTED7.1%
Occupancy HCRIS44.1%
Revenue / Bed COMPUTED$343K
Net-to-Gross HCRIS29.9%
Distress Probability ML54.5%

2. Market Context & Competitive Position

108
AR Hospitals
-7.6%
State Median Margin
32
Comparable Hospitals

AR has 108 Medicare-certified hospitals with a median operating margin of -7.6%. The target's margin of 7.1% places it above the state median. Among 32 size-comparable peers (60-240 beds), the median margin is 1.9%. The target performs in line with or above peers.

3. RCM Performance Analysis — Comparable Hospitals

Comps selected by bed count (60-240), prioritizing same-state peers. 32 hospitals in the comp set.

HospitalStateBedsRevenueMargin
BAPTIST HEALTH REHABILITATION (Target)AR120$41.1M7.1%
MERCY MEDICAL CENTERAR236$366.7M7.7%
BAXTER REGIONAL MEDICAL CENTERAR169$282.2M-2.8%
BAPTIST HEALTH MEDICAL CENTER-AR200$278.0M0.2%
ST. VINCENT HOT SPRINGSAR220$258.6M6.6%
WHITE COUNTY MEDICAL CENTERAR179$251.3M3.4%
WHITE RIVER MEDICAL CENTERAR170$247.7M-11.9%
NEA BAPTIST MEMORIAL HOSPITALAR180$246.7M1.0%
CONWAY REGIONAL MEDICAL CENTERAR169$232.9M-14.5%

4. Predicted Improvement Opportunities

Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $3.0M (736bps margin improvement).

LeverCurrentTargetEBITDA ImpactMarginRamp
Net Collection Rate93.5%97.0%$864K+210bp18mo
Cost to Collect4.5%2.5%$823K+200bp12mo
Denial Rate Reduction12.0%6.5%$815K+198bp12mo
A/R Days Reduction5200.0%3800.0%$501K+122bp9mo
Clean Claim Rate88.0%96.0%$26K+6bp6mo

5. EBITDA Bridge

Net Collection Rate
$864K
Cost to Collect
$823K
Denial Rate Reduction
$815K
A/R Days Reduction
$501K
Clean Claim Rate
$26K
Total EBITDA Uplift$3.0M
Current EBITDA$2.9M
+ RCM Uplift+$3.0M
Pro Forma EBITDA$5.9M
Current Margin7.1%
Pro Forma Margin14.4%
WC Released (1x)$1.6M

6. Returns Analysis — Scenario Matrix

5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.

ScenarioEntryExitEquity InEquity OutMOICIRR
Base Case10.0x10.0x$4.5M$49.4M11.07x61.7%
Base (11x exit)10.0x11.0x$4.5M$55.8M12.50x65.7%
Bull Case9.0x11.0x$4.0M$67.3M16.73x75.7%
Bull (12x exit)9.0x12.0x$4.0M$74.6M18.55x79.3%
Bear Case11.0x10.0x$4.9M$32.8M6.68x46.2%
Bear (11x exit)11.0x11.0x$4.9M$37.7M7.68x50.3%

7. Key Risks & Mitigants

SeverityRisk FactorMitigant
HighElevated distress probabilityModel estimates 54.5% probability of financial distress. Mitigant: distressed entry pricing (7-9x) compensates for risk

8. Data Sources & Methodology Appendix

Data Sources

  • CMS HCRIS Cost Reports (Medicare-certified hospitals)
  • CMS Medicare Utilization (DRG-level volumes)
  • CMS Chronic Conditions (county-level disease prevalence)
  • HCRIS multi-year trend data (financial time series)

Comparable Selection

  • 32 hospitals with 60-240 beds
  • Same-state prioritization (n=33)
  • Comp margins: P25=-11.7% / P50=1.9% / P75=7.9%

Bridge Methodology

  • Targets: P75 of comparable peers (60% gap closure)
  • Denial: avoidable share = 35% of delta × NPR
  • AR: bad debt coefficient = $0.65 per day per $1K NPR
  • NCR: 60% coefficient on collection rate improvement
  • CDI: 0.75% of Medicare revenue per 0.01 CMI point

Returns Assumptions

  • Leverage: 5.5x entry (84.6% debt / 15.4% equity)
  • Organic growth: 3% annual EBITDA growth
  • Debt paydown: 10% of principal per year
  • Hold period: 5 years

Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.